Full Press Release Details
Viking Therapeutics to Present at SVB Securities Global Biopharma Conference.
VKTX
Viking Therapeutics to Present at SVB Securities Global Biopharma Conference
Key Takeaway: Viking Therapeutics to Present at SVB Securities Global Biopharma Conference
Price reaction · baseline $9.56 (2023-02-06 close) · hit after-hours · 1 other VKTX headline(s) in the window, move may be shared
day 0 close · peak
+4.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss